Drugs / Panzytrat
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01430234 | Oct 2011 → Feb 2013 | chronic pancreatitis, exocrine pancreatic insufficiency | Foundation for Liver Research | Completed | No outcome recorded |
| Phase 4 | NCT01327703 | Apr 2011 → May 2012 | cystic fibrosis, exocrine pancreatic insufficiency | Forest Laboratories | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Panzytrat | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01430234 ↗ |
| Action | Restore | “pancreatic enzyme replacement” NCT01430234 ↗ |
| Modality | Protein / enzyme biologic | “pancreatic enzymes” NCT01430234 ↗ |
| Route | Oral | “Panzytrat® 25,000 capsule will be given orally daily” NCT01327703 ↗ |